Mutations in the gene Lrrk2 account for 5–6 % of patients with familial PD and 1–3 % of sporadic cases, but most Lrrk2 transgenic mouse models showed minimal or no neurodegeneration [14]. The gene discussed is LRRK2; the disease is Parkinson disease.